Suppr超能文献

镇静与记忆:组胺H-1受体拮抗剂的研究

Sedation and memory: studies with a histamine H-1 receptor antagonist.

作者信息

Turner Claire, Handford Alison D F, Nicholson Anthony N

机构信息

QinetiQ Centre for Human Sciences, Farnborough, UK.

出版信息

J Psychopharmacol. 2006 Jul;20(4):506-17. doi: 10.1177/0269881106059804. Epub 2006 Jan 9.

Abstract

The influence of sedation on the effect of an H-1 receptor antagonist on various cognitive functions, including memory, were evaluated. Diphenhydramine (50, 75 and 100 mg) and lorazepam (0.5 and 1.5 mg) were given on single occasions to 12 healthy volunteers (six males, six females) aged 20-33 (mean 23.4) years. Subjective assessments of sedation, sleep latencies, digit symbol substitution, choice reaction time, sustained attention and memory recall were studied 1.0 h before and 0.5, 2.0 and 3.5 h after drug ingestion. The study was double blind, placebo controlled and with a crossover design. With all doses of diphenhydramine there was subjective sedation, reduced sleep latencies and impairments in performance on the digit symbol substitution, choice reaction time and sustained attention tasks. No effects were observed with 0.5 mg lorazepam. With 1.5 mg lorazepam there was subjective sedation, fewer digit symbol substitutions, slowed choice reaction time, impaired attention and memory, but no effect on sleep latencies. Contrast analysis of data measured at all time points showed that although there was no difference in the effect of diphenhydramine (100 mg) and lorazepam (1.5 mg) on those tasks without a memory component, response times were slower with lorazepam on those tasks with a memory component. However, both 100 mg diphenhydramine and 1.5 mg lorazepam impaired prompted recall measured at 2 h post-ingestion only. It is considered that impaired memory is not necessarily associated with sedation, and that impairment of memory with drugs that lead to sedation may be effected through neuronal systems independent of those that affect arousal.

摘要

评估了镇静对H-1受体拮抗剂对包括记忆在内的各种认知功能的影响。将苯海拉明(50、75和100毫克)和劳拉西泮(0.5和1.5毫克)单次给予12名年龄在20 - 33岁(平均23.4岁)的健康志愿者(6名男性,6名女性)。在药物摄入前1.0小时以及摄入后0.5、2.0和3.5小时,研究了对镇静的主观评估、睡眠潜伏期、数字符号替换、选择反应时间、持续注意力和记忆回忆。该研究采用双盲、安慰剂对照和交叉设计。所有剂量的苯海拉明都有主观镇静作用,睡眠潜伏期缩短,并且在数字符号替换、选择反应时间和持续注意力任务的表现上有损害。0.5毫克劳拉西泮未观察到效果。1.5毫克劳拉西泮有主观镇静作用,数字符号替换减少,选择反应时间减慢,注意力和记忆力受损,但对睡眠潜伏期无影响。对所有时间点测量的数据进行对比分析表明,虽然苯海拉明(100毫克)和劳拉西泮(1.5毫克)对那些没有记忆成分的任务的影响没有差异,但在那些有记忆成分的任务中,劳拉西泮的反应时间较慢。然而,仅在摄入后2小时测量时,100毫克苯海拉明和1.5毫克劳拉西泮都损害了提示回忆。据认为,记忆受损不一定与镇静相关,并且导致镇静的药物对记忆的损害可能是通过独立于影响觉醒的神经元系统来实现的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验